Your browser doesn't support javascript.
loading
Anaphylactic shock in a small cell lung cancer patient receiving atezolizumab therapy: a rare but potentially fatal complication.
Zhao, Yizhuo; Peng, Wei; Abbas, Muhammad; Shi, Meiqi; Tang, Yiqun; Wang, Li; Yan, Huiying.
Affiliation
  • Zhao Y; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR China.
  • Peng W; Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, PR China.
  • Abbas M; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR China.
  • Shi M; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR China.
  • Tang Y; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing, PR China.
  • Wang L; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, PR China. shimeiqi1963@163.com.
  • Yan H; Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, PR China.
Invest New Drugs ; 40(1): 209-214, 2022 02.
Article in En | MEDLINE | ID: mdl-34398354

Full text: 1 Database: MEDLINE Main subject: Small Cell Lung Carcinoma / Antibodies, Monoclonal, Humanized / Immune Checkpoint Inhibitors / Anaphylaxis / Lung Neoplasms Limits: Aged / Humans / Male Language: En Year: 2022 Type: Article

Full text: 1 Database: MEDLINE Main subject: Small Cell Lung Carcinoma / Antibodies, Monoclonal, Humanized / Immune Checkpoint Inhibitors / Anaphylaxis / Lung Neoplasms Limits: Aged / Humans / Male Language: En Year: 2022 Type: Article